Brian Abrahams
Stock Analyst at RBC Capital
(4.58)
# 968
Out of 5,032 analysts
1819
Total ratings
49.3%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $37 | $19.74 | +87.44% | 16 | Oct 5, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $70 | $36.57 | +91.41% | 36 | Oct 1, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $737 | $738.72 | -0.23% | 86 | Sep 29, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Hold | $6 | $5.00 | +20.00% | 11 | Sep 24, 2026 | |
| LKFT Lakefront Biotherapeutics NV | Upgraded: Buy | $26 → $45 | $29.32 | +53.48% | 60 | Sep 23, 2026 | |
| INCY Incyte | Reiterated: Hold | $109 | $112.73 | -3.31% | 139 | Sep 22, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $23 → $21 | $12.65 | +66.01% | 16 | Sep 21, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $198 → $187 | $145.51 | +28.51% | 96 | Sep 21, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $66 | $35.62 | +85.29% | 23 | Sep 11, 2026 | |
| BCRX BioCryst Pharmaceuticals | Downgraded: Hold | $13 → $11 | $7.95 | +38.36% | 101 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $123 | $144.23 | -14.72% | 214 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $21 | $6.61 | +217.70% | 7 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $17.55 | +156.41% | 2 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $112 | $105.98 | +5.68% | 9 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $240 → $260 | $222.89 | +16.65% | 201 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.471 | +961.57% | 22 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.6499 | +1,130.96% | 109 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $5.78 | +522.84% | 33 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $570 | $502.31 | +13.48% | 152 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.03 | +94.17% | 31 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $19.55 | +104.60% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $10.95 | +55.25% | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $36 | $22.60 | +59.29% | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $23 → $5 | $4.75 | +5.26% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.2834 | +252.86% | 7 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $42 | $21.52 | +95.17% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $8.02 | +62.09% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $17.31 | +9.76% | 136 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $63.70 | +33.44% | 102 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 | $79.25 | +61.51% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39.00 | $48.65 | -19.84% | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $15 | $12.17 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $288 | $12.29 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.37 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $402.60 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $5.01 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $207.58 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $14.46 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $132.13 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $13.00 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $44.26 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $71.73 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $23.06 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0002 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $9.97 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $103.52 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $31.01 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $21.56 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $40.02 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $86.43 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $56.22 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $266.69 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $59.59 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.49 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,157.49 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $254.78 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.40 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $141.94 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $27.50 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $140.79 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $46.11 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.73 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.32 | n/a | 1 | Sep 2, 2009 |
Acadia Pharmaceuticals
Oct 5, 2026
Reiterated: Buy
Price Target: $37
Current: $19.74
Upside: +87.44%
Xenon Pharmaceuticals
Oct 1, 2026
Reiterated: Buy
Price Target: $70
Current: $36.57
Upside: +91.41%
Regeneron Pharmaceuticals
Sep 29, 2026
Reiterated: Hold
Price Target: $737
Current: $738.72
Upside: -0.23%
Aardvark Therapeutics
Sep 24, 2026
Reiterated: Hold
Price Target: $6
Current: $5.00
Upside: +20.00%
Lakefront Biotherapeutics NV
Sep 23, 2026
Upgraded: Buy
Price Target: $26 → $45
Current: $29.32
Upside: +53.48%
Incyte
Sep 22, 2026
Reiterated: Hold
Price Target: $109
Current: $112.73
Upside: -3.31%
Contineum Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $23 → $21
Current: $12.65
Upside: +66.01%
Neurocrine Biosciences
Sep 21, 2026
Reiterated: Buy
Price Target: $198 → $187
Current: $145.51
Upside: +28.51%
Definium Therapeutics
Sep 11, 2026
Reiterated: Buy
Price Target: $66
Current: $35.62
Upside: +85.29%
BioCryst Pharmaceuticals
Sep 10, 2026
Downgraded: Hold
Price Target: $13 → $11
Current: $7.95
Upside: +38.36%
Sep 9, 2026
Reiterated: Hold
Price Target: $123
Current: $144.23
Upside: -14.72%
Sep 8, 2026
Reiterated: Buy
Price Target: $29 → $21
Current: $6.61
Upside: +217.70%
Sep 2, 2026
Reiterated: Buy
Price Target: $45
Current: $17.55
Upside: +156.41%
Sep 2, 2026
Reiterated: Hold
Price Target: $112
Current: $105.98
Upside: +5.68%
Aug 25, 2026
Rated: Buy
Price Target: $240 → $260
Current: $222.89
Upside: +16.65%
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $0.471
Upside: +961.57%
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $0.6499
Upside: +1,130.96%
Aug 12, 2026
Reiterated: Buy
Price Target: $36
Current: $5.78
Upside: +522.84%
Aug 12, 2026
Reiterated: Buy
Price Target: $570
Current: $502.31
Upside: +13.48%
Aug 11, 2026
Reiterated: Hold
Price Target: $2
Current: $1.03
Upside: +94.17%
Aug 10, 2026
Reiterated: Buy
Price Target: $40
Current: $19.55
Upside: +104.60%
Aug 10, 2026
Reiterated: Hold
Price Target: $16 → $17
Current: $10.95
Upside: +55.25%
Aug 10, 2026
Reiterated: Buy
Price Target: $33 → $36
Current: $22.60
Upside: +59.29%
Aug 10, 2026
Upgraded: Hold
Price Target: $23 → $5
Current: $4.75
Upside: +5.26%
Aug 9, 2026
Reiterated: Hold
Price Target: $1
Current: $0.2834
Upside: +252.86%
Aug 6, 2026
Reiterated: Buy
Price Target: $40 → $42
Current: $21.52
Upside: +95.17%
Aug 6, 2026
Reiterated: Hold
Price Target: $13
Current: $8.02
Upside: +62.09%
Aug 5, 2026
Reiterated: Hold
Price Target: $19
Current: $17.31
Upside: +9.76%
Jul 30, 2026
Reiterated: Hold
Price Target: $85
Current: $63.70
Upside: +33.44%
Apr 7, 2026
Reiterated: Buy
Price Target: $128
Current: $79.25
Upside: +61.51%
Oct 26, 2025
Reiterated: Buy
Price Target: $39.00
Current: $48.65
Upside: -19.84%
Oct 2, 2023
Reiterated: Hold
Price Target: $25 → $15
Current: $12.17
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: $288
Current: $12.29
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: $4
Current: $2.37
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $402.60
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $5.01
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $207.58
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $14.46
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $132.13
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $13.00
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $44.26
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $71.73
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $23.06
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0002
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $9.97
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $103.52
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $31.01
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $21.56
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $40.02
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $86.43
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $56.22
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $266.69
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $59.59
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $7.49
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,157.49
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $254.78
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $1.40
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $141.94
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $27.50
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $140.79
Upside: n/a
Feb 23, 2015
Reiterated: Hold
Price Target: n/a
Current: $46.11
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.73
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $11.32
Upside: n/a